egnite, Inc. and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Apr 6, 2024--

Related Keywords

Munich ,Bayern ,Germany ,Aliso Viejo ,California ,United States ,Irvine ,Qatar ,Torrey Loper ,Marissa Bych ,Valiance Life Sciences ,Qatar Investment Authority ,Jenavalve Technology Inc ,Bain Capital Life Sciences ,Peijia Medical ,Company Trilogy ,Jenavalve Technology ,American College ,Annual Scientific Session ,Structural Heart Program ,Morristown Medical Center ,Gagnon Cardiovascular ,Valve Technology ,Heart Valve System ,Trilogy System ,Breakthrough Device Designation ,Trilogy Heart Valve System ,Andera Partners ,Rosetta Capital ,Cormorant Asset Management ,Legend Capital ,Neomed Management ,Pictet Alternative Advisors ,Innovatus Capital Partners ,Business Wire ,